PE20080183A1 - TRA COMBINATION THERAPIES - Google Patents
TRA COMBINATION THERAPIESInfo
- Publication number
- PE20080183A1 PE20080183A1 PE2007000416A PE2007000416A PE20080183A1 PE 20080183 A1 PE20080183 A1 PE 20080183A1 PE 2007000416 A PE2007000416 A PE 2007000416A PE 2007000416 A PE2007000416 A PE 2007000416A PE 20080183 A1 PE20080183 A1 PE 20080183A1
- Authority
- PE
- Peru
- Prior art keywords
- refers
- tra
- receptor antagonist
- combination therapies
- receptor
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Gynecology & Obstetrics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
SE REFIERE A UNA COMPOSICION FARMACEUTICA QUE COMPRENDE UN ANTAGONISTA RECEPTOR DE TROMBINA Y UN AGENTE CARDIOVASCULAR SELECCIONADO DE BLOQUEDORES DE CANALES DE CALCIO TAL COMO AMLODIPINA, DILTIAZEM, VERAPAMIL, ENTRE OTROS, ESTATINAS TALES COMO FLUVASTATINA, LOVASTATINA, PRAVASTATINA, ENTRE OTROS, HEPARINAS DE BAJO PESO MOLECULAR SELECCIONADO DE DALTEPARINA, ARDEPARINA, ENOXAPARINA, ENTRE OTROS, ANTIARRITMICOS SELECCIONADOS DE DOFETILIDA, ATENOLOL, PROPANOLOL, ENTRE OTROS, BLOQUEDORES ADRENERGICOS, IECA, BLOQUEADOR DEL RECEPTOR ANGIOTENSINA II, ANTAGONISTA DE ENDOTELINA, ENTRE OTROS. UN ANTAGONISTA RECEPTOR DE TROMBINA ES A, B, C, ENTRE OTROS. TAMBIEN SE REFIERE A UN PROCEDIMIENTO DE PREPARACION. DICHA COMPOSICION ES UTIL EN EL TRATAMIENTO DE SINDROMES CORONARIOS Y PREVENCION SECUNDARIA EN PACIENTES SUCEPTIBLES A EVENTOS CARDIOVASCULARESREFERS TO A PHARMACEUTICAL COMPOSITION THAT INCLUDES A TROMBIN RECEPTOR ANTAGONIST AND A CARDIOVASCULAR AGENT SELECTED FROM CALCIUM CHANNEL BLOCKERS SUCH AS AMLODIPINE, DILTIAZEM, VERAPAMIL, BETWEEN OTHERS, LOVASTRAIN OTHERS, STATUVASTINAS TALES SELECTED MOLECULAR WEIGHT OF DALTEPARIN, ARDEPARIN, ENOXAPARIN, AMONG OTHERS, SELECTED ANTIARRHYTHMICS OF DOFETILIDE, ATENOLOL, PROPANOLOL, AMONG OTHERS, ADRENERGIC BLOCKERS, ANGOTHETIC, RECEPTOR II BLOCKER. A THROMBINE RECEPTOR ANTAGONIST IS A, B, C, AMONG OTHERS. IT ALSO REFERS TO A PREPARATION PROCEDURE. SUCH COMPOSITION IS USEFUL IN THE TREATMENT OF CORONARY SYNDROMES AND SECONDARY PREVENTION IN PATIENTS SUBSEQUENT TO CARDIOVASCULAR EVENTS
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US79046906P | 2006-04-06 | 2006-04-06 | |
US80861106P | 2006-05-26 | 2006-05-26 | |
US80978506P | 2006-05-31 | 2006-05-31 | |
US83948406P | 2006-08-23 | 2006-08-23 | |
US83947406P | 2006-08-23 | 2006-08-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20080183A1 true PE20080183A1 (en) | 2008-03-10 |
Family
ID=38458156
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2007000416A PE20080183A1 (en) | 2006-04-06 | 2007-04-04 | TRA COMBINATION THERAPIES |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP2001471A1 (en) |
JP (1) | JP2009532487A (en) |
AR (1) | AR060354A1 (en) |
AU (1) | AU2007235353A1 (en) |
BR (1) | BRPI0710840A2 (en) |
CA (1) | CA2648613A1 (en) |
MX (1) | MX2008012933A (en) |
NO (1) | NO20084677L (en) |
PE (1) | PE20080183A1 (en) |
TW (1) | TW200812619A (en) |
WO (1) | WO2007117621A1 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI367112B (en) * | 2006-06-30 | 2012-07-01 | Schering Corp | Immediate-release tablet formulations of a thrombin receptor antagonist |
UA99638C2 (en) * | 2007-12-11 | 2012-09-10 | Баер Шеринг Фарма Акциенгезельшафт | Oxazolidinones for the treatment and/or prophylaxis of heart failure |
BRPI0906395A2 (en) * | 2008-01-11 | 2016-11-01 | Eisai R&D Man Co Ltd | pharmaceutical composition, use of at least one compound or a pharmacologically acceptable salt thereof, kit, and method for treating or ameliorating heart disease |
WO2009124103A2 (en) * | 2008-04-02 | 2009-10-08 | Schering Corporation | Combination therapies comprising par1 antagonists with par4 antagonists |
WO2010144339A2 (en) * | 2009-06-08 | 2010-12-16 | Schering Corporation | A thrombin receptor antagonist and clopidogrel fixed dose tablet |
US20130183392A1 (en) * | 2011-07-15 | 2013-07-18 | Steven Moore | Insect repellant and system |
KR20140028971A (en) * | 2012-08-31 | 2014-03-10 | 한미약품 주식회사 | Bilayered tablet composite formulation of atorvastatin, irbesartan and magnesium carbonate |
CN105125504A (en) * | 2015-09-17 | 2015-12-09 | 青岛华之草医药科技有限公司 | Composition granules of blood lipid-lowering drug pitavastatin calcium |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040192753A1 (en) * | 2000-06-15 | 2004-09-30 | Samuel Chackalamannil | Methods of use of thrombin receptor antagonists |
US7235567B2 (en) * | 2000-06-15 | 2007-06-26 | Schering Corporation | Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist |
US7488742B2 (en) * | 2000-06-15 | 2009-02-10 | Schering Corporation | Thrombin receptor antagonists |
EP2065384B1 (en) * | 2002-04-16 | 2011-01-05 | Schering Corporation | Tricyclic thrombin receptor antagonist |
CA2567981C (en) * | 2004-05-28 | 2010-08-31 | Schering Corporation | Constrained himbacine analogs as thrombin receptor antagonists |
CA2582639A1 (en) * | 2004-10-08 | 2006-04-20 | Schering Corporation | Thrombin receptor antagonists |
CN101146781A (en) * | 2005-03-31 | 2008-03-19 | 先灵公司 | Spirocyclic thrombin receptor antagonists |
JP2009521458A (en) * | 2005-12-22 | 2009-06-04 | シェーリング コーポレイション | Oxazoloisoquinoline derivatives as thrombin receptor antagonists |
WO2007075964A2 (en) * | 2005-12-22 | 2007-07-05 | Schering Corporation | Thrombin receptor antagonists as prophylaxis to complications from cardiopulmonary surgery |
-
2007
- 2007-04-04 PE PE2007000416A patent/PE20080183A1/en not_active Application Discontinuation
- 2007-04-04 AR ARP070101439A patent/AR060354A1/en not_active Application Discontinuation
- 2007-04-04 TW TW096112178A patent/TW200812619A/en unknown
- 2007-04-05 MX MX2008012933A patent/MX2008012933A/en unknown
- 2007-04-05 CA CA002648613A patent/CA2648613A1/en not_active Abandoned
- 2007-04-05 EP EP07755024A patent/EP2001471A1/en not_active Withdrawn
- 2007-04-05 BR BRPI0710840-0A patent/BRPI0710840A2/en not_active IP Right Cessation
- 2007-04-05 WO PCT/US2007/008612 patent/WO2007117621A1/en active Application Filing
- 2007-04-05 AU AU2007235353A patent/AU2007235353A1/en not_active Abandoned
- 2007-04-05 JP JP2009504321A patent/JP2009532487A/en not_active Withdrawn
-
2008
- 2008-11-05 NO NO20084677A patent/NO20084677L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2007117621A1 (en) | 2007-10-18 |
NO20084677L (en) | 2008-11-05 |
EP2001471A1 (en) | 2008-12-17 |
JP2009532487A (en) | 2009-09-10 |
CA2648613A1 (en) | 2007-10-18 |
BRPI0710840A2 (en) | 2011-08-23 |
AR060354A1 (en) | 2008-06-11 |
MX2008012933A (en) | 2008-10-15 |
AU2007235353A1 (en) | 2007-10-18 |
TW200812619A (en) | 2008-03-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE20080183A1 (en) | TRA COMBINATION THERAPIES | |
GT201400102A (en) | 4-PHENYL-PYRIDINES REPLACED FOR THE TREATMENT OF DISEASES RELATED TO THE RECEIVER OF NK1 | |
BR112017013368A2 (en) | polymer blend composition | |
CL2013000713A1 (en) | Pirazin-2-carbonyl-imino-1,3,8-triaza-spiro- [4.5] -decan-substituted compounds, epithelial sodium channel blockers (enac); pharmaceutical composition that includes them; prevention or treatment method; and its use to treat a disease or condition mediated by blockade of the epithelial sodium channel. | |
HN2011002022A (en) | SOLID PHARMACEUTICAL COMPOSITION INCLUDING AMLODIPINA AND LOSARTAN | |
EP2614860A4 (en) | Pharmaceutical composition for the treatment of dry eye | |
ECSP11011019A (en) | ISONICOTINAMIDE OREXINE RECEIVER ANTAGONISTS | |
CL2012003211A1 (en) | Compounds derived from piperidinyl substituted lactams, modulators of gpr119; process to prepare the compounds; pharmaceutical composition comprising the compounds; and use of the compounds in the preparation of medicaments for the treatment or prevention of type 2 diabetes, obesity and related conditions | |
HK1154795A1 (en) | Pharmaceutical compositions of paclitaxel, paclitaxel analogs or paclitaxel conjugates and related methods of preparation and use | |
CL2013003527A1 (en) | Heterocyclic antagonist compounds of muscarinic receptors and agonists of the beta2 adrenergic receptor; its pharmaceutical composition; its combination; a device and its use in the prevention and / or treatment of broncho-obstructive or inflammatory diseases such as asthma and epoc. | |
AR080295A1 (en) | COMPOSITIONS FOR ORAL CARE AND TREATMENT METHODS | |
CL2012002716A1 (en) | Use of a dgat1 inhibitor compound because it is useful in the prevention, delay of progress or treatment of a disease or condition selected from chylomicronemia, familial chylomicronemia syndrome and type v hyperlipoproteinemia; a compound derived from substituted heteroaryl; pharmaceutical composition | |
ECSP15007358A (en) | PIRROL CARBOXAMIDES SUBSTITUTED FLUOROMETHYL | |
GT201300241A (en) | ANTIHIPERTENSIVE PHARMACEUTICAL COMPOSITION | |
CL2008000430A1 (en) | COMPOUNDS DERIVED FROM SUBSTITUTED CONDENSED HETEROCICLES; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS, USEFUL FOR THE TREATMENT OF ONE OR MORE CONDITIONS ASSOCIATED WITH A2C ADRENERGIC RECEIVERS, SUCH AS CONGESTION ASSOCIATED WITH | |
UY33509A (en) | METHODS AND COMPOSITIONS FOR ALLERGY TREATMENT | |
CR20110209A (en) | SOLID PHARMACEUTICAL COMPOSITION | |
CR20110302A (en) | ESPIRO AZEPAN OXAZOLIDINONAS AS BLOCKERS OF THE POTASSIUM CHANNEL Kv1.3 | |
CL2009000660A1 (en) | Use of a protease-activated receptor 2 (par2) antagonist to treat, inhibit, or relieve pain. | |
UY38707A (en) | NEW CYCLIC ANTAGONISTS OF BRADIQUININ B2 RECEPTOR | |
EA201390603A1 (en) | MULTI-LAYER PHARMACEUTICAL COMPOSITION CONTAINING TELMISARTAN AND AMLODIPIPIN | |
HN2012001262A (en) | NEW DERIVATIVES OF 8HETEROYCYCLE-CONDENSED PIPERIDINE) - (PIPERAZINIL) -1-ALCANONE OR (CONCENSED HETEROYCYCLE-PIRROLIDINE) - (PIPERAZINIL) -1-ALCANONE AND ITS USE AS P75 INHIBITORS | |
MX2011007940A (en) | Oligomer-phenothiazine conjugates. | |
EA201290851A1 (en) | METHODS AND COMPOSITIONS FOR THE TREATMENT OR PREVENTION OF THE SYMPTOMS OF HORMONAL CHANGES | |
EA201170913A1 (en) | PHARMACEUTICAL COMPOSITIONS OF OLMESARTAN |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Refusal |